Brain Tumor Education Resource
Brain tumor series #1: MENINGIOMA
This series covers:
- Sphenoid wing WHO grade I meningioma
- Parafalcine WHO grade II meningioma
- Intraosseous meningioma
- Brainstem region meningioma
For each of these cases, the following format is used:
- Brain tumor background: An introduction to the type of brain tumor being case-presented.
- Brain tumor clinical presentation: What were the brain tumor 's symptoms and signs?
- Brain tumor diagnostic workup: What investigations were used to diagnose the brain tumor?
- Brain tumor treatment paradigm: What were the options and proposed treatment for the brain tumor?
- Brain tumor operative procedure and approach: What specific approach did the surgeon use for the brain tumor?
- Brain tumor technical nuances and potential surgical pitfalls: What were important considerations for the brain tumor surgery?
- Where available, brain tumor pre- and post- and/or intra-operative radiological images will be shown for the following brain tumor case examples.
Please note:
- For neurosurgical patients and their families, reader-friendly and practical details of basic brain anatomy, symptoms and signs of neurosurgical lesions, step-by-step investigation and operative procedure details, operative risk counselling, informed consent, recovery and rehabilitation issues, follow-up and salvage recommendations, FAQs and other case histories are all presented elsewhere.
- The information given below is for patients and physicians alike. However, certain areas such as those pertaining to the surgical aspects of the case are more medical jargon-intensive, being particularly suited for neurosurgical trainee teaching purposes. See elsewhere for comprehensive patient-oriented surgical information.
Introduction to meningiomas
A meningioma is a tumor that originates from so-called arachnoid cap cells that are associated with the arachnoid membrane. Note that meningiomas do not arise from fibroblasts of the dural membrane. Frequently, arachnoid cap cells are found near structures called arachnoid granulations which drain the cerebrospinal fluid (CSF). Arachnoid cap cells are also found near the tela choroidea, a layer in the ventricles of the brain. The vast majority of meningiomas are benign in that they grow slowly, and are well-demarcated from their surrounding tissues - i.e., they don't tend to invade nearby structures but rather compress or displace those structures. Most feel rubbery to touch. They may or may not be calcified ("gritty" when cut). The vast majority of meningiomas are "graded" by the World Health Organization (WHO) as being WHO Grade I (typical, benign meningiomas; 90%). Even though most meningiomas are benign, they can still cause neurological problems, sometimes significant. This depends on their size and location, in particular which structure(s) a meningioma compresses or displaces. For example, certain structures that can be "compromised" by an expanding meningioma include the superior sagittal sinus (a large venous structure overlying the brain's surface), the optic chiasm (for vision), the frontal lobes (for personality, planning and judgement), the brainstem and spinal cord (for movement and sensation), and so forth. Sometimes menigiomas are found in multiple locations in the central nervous system (CNS) of a given individual at the time of initial diagnosis. In such persons, there may be a condition known as meningiomatosis, and there may be an association with a hereditary condition such as neurofibromatosis, or a history of childhood radiation therapy. Much less commonly, there are so-called atypical meningiomas (6-7%) and malignant or anaplastic meningiomas (3-4%). As a rule of thumb, atypical and malignant meningioma classifications tend to correlate with more rapid growth and more brain tissue invasion. Depending on the location, size, presence of any neurological effects, and rate of growth of a meningioma, the tumor may be "observed" or treated. Treatment is usually by open surgery, but in some cases focused radiation therapy (stereotactic radiosurgery or SRS such as GammaKnife, CyberKnife, Novalis or Linac) may be an appropriate alternative. In some cases, surgery and SRS are used in combination.
Brain Tumor section; Case 1 - Sphenoid wing WHO grade I meningioma
Background: The sphenoid bone is a base-of-skull bone which has an inner half known as the medial sphenoid wing, and an outer flared part known as the lateral sphenoid wing. The medial sphenoid wing lies closely approximated to key cranial nerve and vascular ("neurovascular") structures including the optic nerve, internal carotid artery, cavernous sinus, cranial nerves 3-6, and so forth. The lateral sphenoid wing lies closely approximated to the frontal and temporal lobes and their separation known as the Sylvian or lateral fissure. A sphenoid wing WHO grade I meningioma therefore arises from arachnoid cap cells somewhere along the sphenoid wing, and is a benign tumor, although potentially troublesome depending on its size and its effect upon surrounding brain neurovascular structures.
Clinical presentation: A 55 year old female presented with chronic throbbing headache, more obvious on the right side of her head. Neurological examination was entirely normal.
Diagnostic workup: A head CT scan was carried out, with and without contrast. This showed a large right-sided frontotemporal mass, which enhanced ("lit up") uniformly following administration of intravenous contrast. A brain MRI with and without contrast was carried out for further characterization of the mass. Its imaging features were consistent with a large, lateral sphenoid wing meningioma.
Treatment paradigm: Owing to the size of the lesion, and the fact that it was symptomatic, surgery was offered. Risks, benefits and alternatives to surgery were explained to the patient. Stereotactic radiosurgery (SRS) as a first-line treatment option for this tumor in this patient was not considered to be appropriate. It was explained, however, that should the removal (resection) of the tumor be incomplete (which is possible in any kind of tumor surgery in any surgeon's hands), then at some time during follow-up monitoring of the patient, if there was any evidence of tumor recurrence, at that time further surgery and/or SRS could be considered.
Operative procedure/operative approach: The surgical goals were (i) gross-total resection (removal of all the tumor visible to the surgeon's eyes) and (ii) restoration of cosmetic and structural integrity (by removing the involved bone and dura, a potential cosmetic and structural defect would need to be effectively addressed). A right frontotemporal craniotomy, gross-total resection of the tumor, followed by duraplasty and acrylic cranioplasty were uneventfully carried out. Note that these are reasonable goals for most lateral wing of sphenoid meningiomas. For medial sphenoid wing meningiomas, there may be encasement of the critical neurovascular structures of the cavernous sinus region and carotid bifurcation. In cases involving neurovascular encasement, it is generally unrealistic and unsafe to conceive of gross-total resection of the tumor (particularly rubbery or gritty surgically "resistant" tumors), and therefore appropriate debulking (partial, or near-total) followed by SRS may be a more viable approach. The exact surgical plan will vary on a case-by-case basis.
Technical nuances and potential surgical pitfalls: For lateral sphenoid wing meningiomas, the arachnoid plane between the tumor and the peri-Sylvian cortex should be sought and utilized whenever possible. For lateral sphenoid wing meningiomas that extend towards the lesser wing of the sphenoid bone, careful attention must be paid to preservation of the orbital apex structures (particularly when drilling in this vicinity) and the neurovascular structures of the opticocarotid region. For medial sphenoid wing meningiomas, major pitfalls include violation of the middle cerebral artery and its perforators and the carotid bifurcation, and cranial nerves 2, 3 and 4 (either in the cavernous sinus wall or along the tentorial edge). As for their lateral sphenoid wing meningioma counterparts, identification and utilization of an arachnoid plane should also be carried out for medial sphenoid wing meningiomas. Leaving resistant, structure-encasing tumor behind for subsequent SRS is likely to prove prudent. As always, meticulous attention should be paid to early control of any vascular pedicle of the tumor, and to post-resection hemostasis; also to biosynthetic restoration of any resected dura and bone for cosmetic and structural integrity. Postoperative seizure(s) is a risk, albeit transient, in tumors associated with brain (subpial) invasion, or when brain retractors are used.
Imaging:
Image 1.1 (above). Greater wing of sphenoid (GWS) meningioma. Preoperative axial contrast CT. Greater sphenoid wing meningioma encircled.

Image 1.2 (above). GWS versus lesser wing of sphenoid meningioma. Preoperative coronal contrast MRI. Lesser sphenoid wing meningioma shown here (encircled). This image, from another patient, is included for the purpose of comparison with the tumor shown in Image 1.1.

Image 1.3 (above). GWS Meningioma. Intraoperative photo. Greater sphenoid wing meningioma. Dashed circle shows involvement of the overlying bone by the tumor. This is hyperostosis.
Brain Tumor section; Case 2 - Parafalcine WHO grade II meningioma
Background: The falx cerebri is a prominent midline dural membrane separating the left and right hemispheres of the brain. A parafalcine meningioma arises from arachnoid cap cells near to the falx. A parafalcine WHO grade II meningioma is an atypical meningioma arising in this location. Atypia, as mentioned above, implies additional abnormal pathologic/microscopic features to this tumor, that can result in such tumors behaving in a more aggressive manner. Note that the "WHO grade II" classification is determined only after surgery from the operative specimen obtained and sent to the neuropathologist. One of the more important considerations for meningiomas in a para/falcine location is their relationship to the critical midline venous structures such as the superior sagittal sinus and torcula herophili. These large dural venous sinuses carry a tremendous amount of blood along the brain's upper-outer-midline surface and eventually into the internal jugular veins. Tumors arising near such structures can compress ("obstruct") or block ("occlude") blood flow through these veins leading to raised intracranial pressure (from venous hypertension) and sometimes even to venous strokes (venous infarction).
Clinical presentation: A 46 year old male patient experienced several months of dull headache. Immediately prior to presenting to his local doctor, the patient reported tingling and some numbness along the right side of his body. Neurological examination was normal, with the exception of reduced sensation mainly involving the right arm.
Diagnostic workup: A brain CT scan without contrast showed a mass located in the left hemisphere, along the midline. There was some brain swelling or edema associated with the mass. There was no evidence of overlying skull involvement (i.e., no hyperostosis) on the CT bone windows. A brain MRI with and without contrast showed the large mass to have features consistent with a meningioma (relatively uniform contrast enhancement and a thickened "dural tail"). The mass was left parafalcine and was associated with mild surrounding brain edema. A magnetic resonance venogram (MRV) was ordered to determine whether or not the superior sagittal sinus was "open" or "patent". Fortunately, the sinus was open, however the tumor clearly abutted this critical venous structure.
Treatment paradigm: Surgery was offered to the patient owing to the large size of the lesion, its symptomatic presentation, and the eventual direct risk the tumor would confer to the patency of the superior sagittal sinus. It was discussed that should there be a surgical remnant, the patient could be followed with periodic ("serial") imaging (in this case MRI with contrast), and any evidence of recurrent or progressive tumor could be treated with repeat surgery or with focused SRS (see above). The goal of the operation was gross-total resection of the tumor. It was explained to the patient that should there be evidence of brain adherence (stickiness) or some degree of brain invasion by the tumor (less likely, but certainly possible with higher grades of meningioma), this would increase the risk of a postoperative seizure, a risk that would be reduced by the temporary use of an anti-seizure medication (anticonvulsant) during the postoperative convalescence period.
Operative procedure/operative approach: A stereotactic left parietal craniotomy was carried out. Intraoperative image guidance utilized the immediate preoperative contrast MRI multiplanar images. This allowed a more accurately located and optimally measured craniotomy to be carried out. There was evidence of "focal" brain invasion (i.e., "subpial" tumor pentration into the brain cortex in a small area along one of the tumor-brain surfaces), but for the most part the tumor was noninvasive. It could be readily peeled off the vicinity of the superior sagittal sinus. Its origin was determined to be from the dural surface over the paramidline parietal lobe, and not from the falx itself, and this parietal dura along with all the visible tumor were resected uneventfully. A duraplasty was carried out, and the original bone flap immediately restored at the conclusion of the operation. There was no evidence of bone involvement (i.e., no hyperostosis or invasion).
Technical nuances and potential surgical pitfalls: A generous stereotactic craniotomy (creating a bone window that allows for a 1 cm margin around the tumor's margins) should be carried out with careful protection of the sinus during opening. Identification and utilization of the arachnoid plane present between the brain-tumor interface is important. This plane may not be present in certain areas of brain invasion (if any) but nodular tumor may still be seen and felt in such instances. Meticulous dissection off the superior sagittal sinus is required should the tumor abut this structure. A neurosurgeon should always be prepared for sinus violation and blood transfusion in tumors involving or abutting venous sinues. Surgically resistant tumor that adheres to the sinus is best left in situ in order to preserve this venous structure; a focal remnant in this location can readily be treated with postoperative SRS. Another important consideration here is complete removal of any involved dura (in order to achieve a Simpson grade I resection, thereby reducing the risk of tumor recurrence). If this is not possible, bipolar cauterization of any dural remnant is recommended when and where safe to do so. An appropriate biosynthetic duraplasty should also be carried out to restore normal anatomical layers in this setting.
Imaging:

Image 2.1 (above). Parafalcine meningioma. Preoperative MRI sequences (top left is axial post-contrast; bottom left is axial FLAIR; right is coronal post-contrast). Parafalcine parietal meningioma seen (bright egg-shaped mass; brightness from intravenous contrast uptake = strong "enhancement"). Brain edema (swelling) also shown next to the tumor. Dashed circle shows how this tumor abuts the superior sagittal sinus but does not appear to significantly compress or invade this venous structure.

Image 2.2 (above). Parafalcine meningioma. Preoperative MRV sequence. Lateral aspect. Parafalcine parietal meningioma. Dashed circle shows tumor "ghost". SSS = superior sagittal sinus, which is open (i.e., is still "patent").
Brain Tumor section; Case 3 - Intraosseous meningioma
Background: An intraosseous meningioma is one that grows within a bone. Presumably, in this location meningiomas originate from arachnoid cap cell rests (islands) found in or along vascular channels coursing through the skull (such as diploic or emissary veins or nutrient arteries). Frequently the location for an intraosseous meningioma is in the sphenoorbital region (junction of the sphenoid bone's greater wing - "the temple" region - and the bone constituting the orbital cavity - "eye socket"). In this location, proptosis (bulging of the eye on the side of the tumor) with or without visual compromise (e.g., impaired vision, impaired eye movements, chemical or vascular irritation of the eye) is a common presentation.
Clinical presentation: This 62 year old female presented with slowly progressive bulging of the right eye, along with eye congestion (chemosis and scleral injection) but no frank loss of vision (visual acuity) or impairment of eyeball mobility (ocular motility). Physical examination was remarkable for nontender protrusion (proptosis) of the right eye and sclerial injection/chemosis. Extraocular muscle function and visual acuity were normal. There was no tenderness to the right sphenotemporal region, but there was a mild fullness here compared with the left side.
Diagnostic workup: CT head scan with and without contrast showed a mass whose epicenter was the right greater wing of the sphenoid bone. The mass appeared to encroach upon the right orbital contents. There was proptosis noted on the scan. Bone windows and contrast enhancement suggested a right-sided intraoosseous meningioma. A small protrusion of this tumor (focal exophytic component) was noted deep to the right temporal muscle. A brain MRI with and without contrast was obtained which confirmed the CT findings. There was no obvious invasion of the intraorbital contents. Also noted on this study was the close proximity of the inner (medial) aspect of the tumour to the right internal carotid bifurcation.
Treatment paradigm: Surgery was the appropriate recommendation for this symptomatic tumor, particularly in order to prevent the anticipated tumor-related compromise of the patient's right eye function. A combined procedure ("multidisciplinary approach") with a craniofacial plastic surgeon, ophthalmic surgeon and neurosurgeon was planned in order to optimize the safety and efficacy of the procedure.
Operative procedure/operative approach: A right orbitozygomatic craniotomy was carried out, with gross total resection of the tumor. Stereotactic CT bone-window image-guidance was used intraoperatively as this gave excellent real-time information about the location of sphenoorbital drilling in order to avoid drill-encroachment upon the orbital contents and critical neurovascular structures especially near the medial part of the tumor (around the lesser wing of the sphenoid). No separate dural involvement was found. A cranioplasty was carried out at the end of the procedure for both cosmetic and structural reasons.
Technical nuances and potential surgical pitfalls: Stereotactic CT bone-window image guidance and a multidisciplinary approach has been found to be very useful for intraosseous sphenoorbital meningiomas to enhance the safety of the procedure. Particular care should be taken when drilling along the superolateral orbital cavity bone (vicinity of the lateral rectus muscle; includes prevention of possible high-speed drill-syphon effect), and along the medial aspect of the greater wing of sphenoid as one approaches the lesser wing/orbital apex (optic canal and arterial structures of the carotid bifurcation). Further, postoperative CSF leak can occur from a small durotomy in the region of the superior orbital fissure/frontotemporal dural confluence. Any dural involvement by tumor (e.g., nodular or en-plaque) should be managed with dural excision and duraplasty.
Imaging:

Image 3.1 (above). Intraosseous meningioma. Preoperative axial CT bone window on left; preoperative coronal noncontrast CT brain window on right. Intraosseous tumor is marked within the dashed circles. Proptosis noted (eye's globe is pushed forward by encroachment upon the orbital contents by the tumor mass, as readily seen in these images).
Image 3.2 (above). Intraosseous meningioma. Preoperative MRI axial T1 noncontrast sequence. Tumor encircled. Note that its inner (medial) aspect closely abuts critical neurovascular (NV) structures.

Image 3.3 (above). Intraosseous meningioma. Intraoperative photo. The tumor has been removed and acrylic cranioplasty (dashed circle) has now been carried out for cosmetic and structural-support purposes.

Image 3.4 (above). Intraosseous meningioma. Postoperative axial CT bone window. Meningioma entirely removed. Dashed circle shows cranioplasty shadow (and parts of its wire scaffold) where the tumor once was.
Brain Tumor section; Case 4 - Brainstem region meningioma
Background: Meningiomas can occur anywhere in the central nervous system, including in the vicinity of the brainstem. In this location, they can cause significant disability from compression of the brainstem structures resulting in, for example, a variety of cranial nerve palsies (cranial neuropathy), and weakness affecting one or more limbs (including "cruciate paralysis"). Double vision (diplopia), swallowing (dysphagia) and speaking (dysphonia) difficulties, disturbances of facial function (facial paresis), impaired hearing and balance, and limb weakness and spasticity have all been reported in the setting of different brainstem region tumors such as meningiomas. Interestingly, it doesn't take a large-size tumor in this location (the infratentorial space or posterior fossa) to cause significant neurological impairment, mainly because the brainstem region is relatively unaccommodating owing to its restricted dimensions to begin with compared with the space over the brain's convexities (supratentorial space). Finally, it should be noted that hydrocephalus and raised intracranial pressure can result, albeit uncommonly, from brainstem region tumors that obstruct the flow of cerebrospinal fluid anywhere from the cerebral aqueduct (of Sylvius) in the midbrain, down to the bottom part (obex) of the fourth ventricle. Similarly, cerebrospinal fluid build-up in the spinal cord (syringomyelia or syrinx formation) can occur secondary to a compressive brainstem region tumor. Meningiomas and other tumors occuring at the junction of the lower brainstem and upper cervical spinal cord are referred to as craniocervical junction tumors.
Clinical presentation: A 48 year old female presented with slowly progressive loss of muscle bulk (atrophy or wasting) involving the right side of her tongue, and some "clumsiness" of speech and swallowing (i.e., mild dysarthria and dysphagia). Physical examination was normal except for right hemitongue atrophy and deviation consistent with a right hypoglossal nerve (12th cranial nerve) palsy.
Diagnostic workup: A brain MRI was carried out, with and without contrast. This revealed a contrast-enhancing mass with a "dural tail" in the region of the lower brainstem (medulla) on the right side. The mass was located in the vicinity of the right 12th cranial nerve, and explained the patient's symptoms and signs. A CT angiogram (CTA) was subsequently ordered just to confirm that this mass was not an unusual presentation of a brain aneurysm or other vascular abnormality. The CTA suggested this was a solid tumor.
Treatment paradigm: Owing to the age of the patient, and the symptomatic nature of the mass, the patient was recommended for treatment as opposed to "observation". Surgery was favored over stereotactic radiosurgery owing to the surgical accessibility of the mass, the potential for avoidance of brainstem radiation in a relatively young person, and to confirm the diagnosis of meningioma versus some other possibility such as a dural-based metastasis (i.e., a tumor that has spread from another region;
click here to go to the metastasis section; or a Schwannoma;
click here to go to the Schwannoma section). It was explained to the patient that any residual or recurrent tumor could be treated with repeat surgery or with SRS if needed.
Operative procedure/operative approach: A right far lateral craniotomy using a modified "park bench position" was carried out. There was no need for mobilization of the vertebral artery or for occipital condyle drilling in this case. Stereotactic MRI image-guidance was used, as was lower cranial nerve monitoring (electrodes were placed for cranial nerves 11 and 12; an endotracheal tube with electrophysiological recording capacity was used to monotor cranial nerves 9 and 10). In addition, somatosensory- and motor-evoked potential monitoring (SSEP, MEP) was carried out. Immediate preoperative lumbar drain placement was not required owing to early and direct access to the cisterna magna. The far lateral approach in the park bench position allowed excellent visualization and access to the structures of the craniocervical junction, with a 45 degree trajectory across the right anterolateral medulla. The lesion was identified as a meningioma, and a Simpson Grade 2 resection was carried out. Not all of the dural origin could be removed and therefore this origin was bipolar coagulated following gross-total resection of the tumor itself. Fortunately, the 12th cranial nerve was effaced and displaced by the mass, but was not itself incorporated into the tumor. A watertight dural closure was obtained, bolstered by fibrin glue (Tisseel) and local muscle; lumbar drain placement was not necessary here. The original bone-flap was restored.
Technical nuances and potential surgical pitfalls: Meticulous patient positioning and padding for this approach cannot be overstated. The potential for disorientation from the midline can be minimized using intraoperative MRI image-guidance, and following the usual anatomical midline landmarks which should be visualized intraoperatively - i.e., inion, midline external occipital keel and the C1-posterior arch's midline tubercle (all of which may still appear "shifted" or rotated in the modified park bench position). Particular caution must also be paid to the vertebral artery during the exposure - the surrounding venous plexus and yellow-brown fat are good clues to its proximity. CSF leak is a potential complication of posterior fossa surgery, and its incidence can be reduced by measures mentioned above. Lower brainstem cranial nerve monitoring as indicated above is advised for tumors in this location. Motor-evoked potential monitoring is recommended for brainstem surgery, but requires excellent neuroanesthesia experience and coordination.
Imaging:

Image 4.1 (above). Brainstem region meningioma. Preoperative MRI postcontrast coronal (left) and axial (right) images. Small perimedullary (brainstem region) contrast-enhancing mass seen (dashed circle) with a broad based-dural attachment and tail. Very mild effacement of stem, no hydrocephalus.